grepcent public filings, reorganized for comparison

Nano Nuclear Energy Inc. (NNE)

CIK: 0001923891. SIC: 4911 Electric Services. Latest 10-K as of: 2025-12-18.

SIC breadcrumb: Transportation, Communications, Electric, Gas, And Sanitary Services > Electric, Gas, And Sanitary Services > SIC 4911 Electric Services

SEC company page: https://www.sec.gov/edgar/browse/?CIK=1923891. Latest filing source: 0001493152-25-028285.

Informational only. Descriptive public-record data — not a rating, forecast, or investment advice. See Disclaimer.

At a glance

No standardized annual SEC companyfacts metrics were extracted for this company; the at-a-glance panel is omitted rather than estimated.

No market price, no rating, no forecast on this site. Not investment advice.

Peer & cluster context

Peer percentile fingerprint

NNE ratios vs SIC peers. Source: grepcent computed from latest SEC companyfacts ratios; peer set SIC industry 4911; per-ratio N printed.NNE ratios vs SIC peers. Source: grepcent computed from latest SEC companyfacts ratios; peer set SIC industry 4911; per-ratio N printed.RatioNNEPeer medianPercentileNROE-18.0%9.4%428ROA-17.5%2.6%028Liabilities / equity0.032.76028Current ratio53.480.8110028

Percentile = share of the N covered peers reporting that ratio whose value is lower (ties counted half); computed among grepcent-covered companies in SIC industry 4911 Electric Services, not the whole market. A higher percentile means a higher value of the ratio, not a better company. Ratios with fewer than 8 reporting peers are omitted. Latest reported values per company; fiscal periods may differ. Descriptive arithmetic - not a score, rating, or ranking.

Selected Fundamentals

MetricValueUnitFYFiled
Net income-40,067,076USD20252025-12-18
Assets228,656,866USD20252025-12-18

Financials

Annual standardized facts from SEC companyfacts as of latest extracted filing date 2025-12-18. Source: https://data.sec.gov/api/xbrl/companyfacts/CIK0001923891.json. Derived margins, ratios, and free cash flow are computed from the extracted annual SEC facts.

Download these verified figures (annual + quarterly, with per-value filing provenance): JSON · CSV

Flow metrics use full-year FY periods from 10-K/10-K/A filings; balance-sheet metrics use FY-end instants. Free cash flow = operating cash flow - capital expenditures. Missing metrics are omitted rather than fabricated.

Metric2022202320242025
Net income-6,250,401-10,151,556-40,067,076
Diluted EPS-0.28-0.39-1.06
Operating cash flow-3,867,573-8,464,146-19,621,963
Capital expenditures1,700,0008,449,332
Assets7,233,65235,096,170228,656,866
Liabilities225,0053,488,7146,088,138
Stockholders' equity2,109,6762,008,64731,607,456222,568,728
Cash and cash equivalents28,507,257203,265,052
Free cash flow-10,164,146-28,071,295

Ratios

ROE and ROA use period-end equity/assets. Liabilities / equity uses total liabilities divided by stockholders' equity. Current ratio uses current assets divided by current liabilities when both are reported.

Metric2022202320242025
Return on equity-311.17%-32.12%-18.00%
Return on assets-86.41%-28.92%-17.52%
Liabilities / equity0.110.110.03
Current ratio31.8215.9653.48

Industry Peer Context

Each number-line places NNE against the min, median, and max of latest reported values among companies in the same SIC industry when at least three peers report that ratio.

ROE peer context

NNE ROE versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 4911; peer count 28.NNE ROE versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 4911; peer count 28.28 SIC peersMin -20.0%Median 9.4%Max 51.4%NNE -18.0%

ROA peer context

NNE ROA versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 4911; peer count 28.NNE ROA versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 4911; peer count 28.28 SIC peersMin -17.5%Median 2.6%Max 10.3%NNE -17.5%

Financial Bridges

Waterfall figures reconcile reported SEC companyfacts components. Missing bridges are omitted when required components are not present for the same fiscal year.

Free cash flow = operating cash flow - capital expenditures

NNE FY2025 free cash flow bridge from reported figures.NNE FY2025 free cash flow bridge from reported figures.NNE free cash flow bridgeFY2025: operating cash flow less capital expendituresSource: SEC companyfacts FY2025.Free cash flow bridgeReported amount-$250.0M$0.0B$250.0M-$19.6MOperating cash flow-$8.4MCapex-$28.1MFree cash flow

Figure provenance: SEC companyfacts FY 2025. Operating cash flow: accession 0001493152-25-028285; concept NetCashProvidedByUsedInOperatingActivities; source concepts us-gaap:NetCashProvidedByUsedInOperatingActivities | Capital expenditures: accession 0001493152-25-028285; concept PaymentsToAcquirePropertyPlantAndEquipment; source concepts us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | Free cash flow: accession 0001493152-25-028285; concept NetCashProvidedByUsedInOperatingActivities - PaymentsToAcquirePropertyPlantAndEquipment; source concepts us-gaap:NetCashProvidedByUsedInOperatingActivities; us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

Financial Charts

NNE net income, last 3 periods. Source: SEC companyfacts FY2025.NNE net income, last 3 periods. Source: SEC companyfacts FY2025.NNE Net incomeLatest point: FY2025 = -$40.1MSource: SEC companyfacts FY2025.Fiscal yearNet income-$250.0M-$125.0M$0.0BFY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-09-30; accession 0001493152-25-028285; filed 2025-12-18. Concept: NetIncomeLoss. Source concepts: us-gaap:NetIncomeLoss.

NNE diluted eps, last 3 periods. Source: SEC companyfacts FY2025.NNE diluted eps, last 3 periods. Source: SEC companyfacts FY2025.NNE Diluted EPSLatest point: FY2025 = -$1.06/shareSource: SEC companyfacts FY2025.Fiscal yearDiluted EPS (USD/share)-$1.50/share-$0.75/share$0.00/shareFY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-09-30; accession 0001493152-25-028285; filed 2025-12-18. Concept: EarningsPerShareDiluted. Source concepts: us-gaap:EarningsPerShareDiluted.

NNE operating cash flow, last 3 periods. Source: SEC companyfacts FY2025.NNE operating cash flow, last 3 periods. Source: SEC companyfacts FY2025.NNE Operating cash flowLatest point: FY2025 = -$19.6MSource: SEC companyfacts FY2025.Fiscal yearOperating cash flow-$250.0M-$125.0M$0.0BFY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-09-30; accession 0001493152-25-028285; filed 2025-12-18. Concept: NetCashProvidedByUsedInOperatingActivities. Source concepts: us-gaap:NetCashProvidedByUsedInOperatingActivities.

NNE capital expenditures, last 2 periods. Source: SEC companyfacts FY2025.NNE capital expenditures, last 2 periods. Source: SEC companyfacts FY2025.NNE Capital expendituresLatest point: FY2025 = $8.4MSource: SEC companyfacts FY2025.Fiscal yearCapital expenditures$0.0B$125.0M$250.0M$1.7MFY2024$8.4MFY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-09-30; accession 0001493152-25-028285; filed 2025-12-18. Concept: PaymentsToAcquirePropertyPlantAndEquipment. Source concepts: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

NNE assets, last 3 periods. Source: SEC companyfacts FY2025.NNE assets, last 3 periods. Source: SEC companyfacts FY2025.NNE AssetsLatest point: FY2025 = $228.7MSource: SEC companyfacts FY2025.Fiscal yearAssets$0.0B$125.0M$250.0M$7.2MFY2023$35.1MFY2024$228.7MFY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-09-30; accession 0001493152-25-028285; filed 2025-12-18. Concept: Assets. Source concepts: us-gaap:Assets.

NNE liabilities, last 3 periods. Source: SEC companyfacts FY2025.NNE liabilities, last 3 periods. Source: SEC companyfacts FY2025.NNE LiabilitiesLatest point: FY2025 = $6.1MSource: SEC companyfacts FY2025.Fiscal yearLiabilities$0.0B$125.0M$250.0MFY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-09-30; accession 0001493152-25-028285; filed 2025-12-18. Concept: Liabilities. Source concepts: us-gaap:Liabilities.

NNE stockholders' equity, last 4 periods. Source: SEC companyfacts FY2025.NNE stockholders' equity, last 4 periods. Source: SEC companyfacts FY2025.NNE Stockholders' equityLatest point: FY2025 = $222.6MSource: SEC companyfacts FY2025.Fiscal yearStockholders' equity$0.0B$125.0M$250.0M$2.1MFY2022$2.0MFY2023$31.6MFY2024$222.6MFY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-09-30; accession 0001493152-25-028285; filed 2025-12-18. Concept: StockholdersEquity. Source concepts: us-gaap:StockholdersEquity.

NNE cash and cash equivalents, last 2 periods. Source: SEC companyfacts FY2025.NNE cash and cash equivalents, last 2 periods. Source: SEC companyfacts FY2025.NNE Cash and cash equivalentsLatest point: FY2025 = $203.3MSource: SEC companyfacts FY2025.Fiscal yearCash and cash equivalents$0.0B$125.0M$250.0M$28.5MFY2024$203.3MFY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-09-30; accession 0001493152-25-028285; filed 2025-12-18. Concept: CashAndCashEquivalentsAtCarryingValue. Source concepts: us-gaap:CashAndCashEquivalentsAtCarryingValue.

NNE free cash flow, last 2 periods. Source: SEC companyfacts FY2025.NNE free cash flow, last 2 periods. Source: SEC companyfacts FY2025.NNE Free cash flowLatest point: FY2025 = -$28.1MSource: SEC companyfacts FY2025.Fiscal yearFree cash flow-$250.0M-$125.0M$0.0BFY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-09-30; accession 0001493152-25-028285; filed 2025-12-18. Concept: NetCashProvidedByUsedInOperatingActivities - PaymentsToAcquirePropertyPlantAndEquipment. Source concepts: us-gaap:NetCashProvidedByUsedInOperatingActivities; us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

As-reported value updates

No tracked differences above grepcent's stated thresholds and capped precision rule were found between the earliest XBRL-filed value and the value currently on file for the standardized annual metrics grepcent tracks.

Quarterly

Quarterly standardized facts from SEC companyfacts as of latest extracted filing date 2026-08-12. Source: https://data.sec.gov/api/xbrl/companyfacts/CIK0001923891.json.

Flow metrics use discrete quarter-length periods from 10-Q/10-Q/A filings. Q4 revenue and net income are derived only when annual FY and nine-month YTD facts exist for the same fiscal year; derived Q4 values are labeled. EPS Q4 is not derived.

QuarterEnd DateRevenueNet IncomeDiluted EPSMethod
2024-Q22024-03-31-1,677,628-0.07reported discrete quarter
2024-Q32024-06-30-4,668,247-0.17reported discrete quarter
2024-Q42024-09-30-2,491,736derived Q4 = FY annual - nine-month YTD
2025-Q12024-12-31-3,113,362-0.09reported discrete quarter
2025-Q22025-03-31-21,308,721-0.57reported discrete quarter
2025-Q32025-06-30-7,594,583-0.19reported discrete quarter
2025-Q42025-09-30-8,050,410derived Q4 = FY annual - nine-month YTD
2026-Q12025-12-31-6,516,279-0.13reported discrete quarter
2026-Q22026-03-31-9,180,166-0.18reported discrete quarter
2026-Q32026-06-30214,042-10,104,135-0.19reported discrete quarter

Quarterly Charts

NNE quarterly revenue, last 1 periods. Source: SEC companyfacts 2026-Q3.NNE quarterly revenue, last 1 periods. Source: SEC companyfacts 2026-Q3.NNE Quarterly RevenueLatest point: 2026-Q3 = $214.0KSource: SEC companyfacts 2026-Q3.Fiscal quarterQuarterly Revenue$0.0B$125.0M$250.0M2026-Q3

Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-06-30; accession 0001493152-26-037345; filed 2026-08-12. Concept: Revenues. Source concepts: us-gaap:Revenues.

NNE quarterly net income, last 10 periods. Source: SEC companyfacts 2026-Q3.NNE quarterly net income, last 10 periods. Source: SEC companyfacts 2026-Q3.NNE Quarterly Net incomeLatest point: 2026-Q3 = -$10.1MSource: SEC companyfacts 2026-Q3.Fiscal quarterQuarterly Net income-$250.0M-$125.0M$0.0B2024-Q22024-Q32024-Q42025-Q12025-Q22025-Q32025-Q42026-Q12026-Q22026-Q3

Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-06-30; accession 0001493152-26-037345; filed 2026-08-12. Concept: NetIncomeLoss. Source concepts: us-gaap:NetIncomeLoss.

NNE quarterly diluted eps, last 8 periods. Source: SEC companyfacts 2026-Q3.NNE quarterly diluted eps, last 8 periods. Source: SEC companyfacts 2026-Q3.NNE Quarterly Diluted EPSLatest point: 2026-Q3 = -$0.19/shareSource: SEC companyfacts 2026-Q3.Fiscal quarterQuarterly Diluted EPS (USD/share)-$1.00/share-$0.50/share$0.00/share2024-Q22024-Q32025-Q12025-Q22025-Q32026-Q12026-Q22026-Q3

Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-06-30; accession 0001493152-26-037345; filed 2026-08-12. Concept: EarningsPerShareDiluted. Source concepts: us-gaap:EarningsPerShareDiluted.

Business

Read NNE's verbatim Item 1 Business section from its latest 10-K: Business.

Latest quarter (10-Q)

Latest 10-Q source: 0001493152-26-037345.

Extracted from Part I Item 2 to the first post-MD&A boundary after HTML sanitization. Published MD&A gate trimmed front/tail over-capture. Confidence: high. Filing date: 2026-08-12. Report date: 2026-06-30.

Item
2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

You
should read the following discussion and analysis of our financial condition and results of operations of the unaudited financial statements
and related notes included elsewhere in this Report. Data as of and for the year ended September 30, 2025 has been derived from our audited
consolidated financial statements. Data as of and for the three and nine months ended June 30, 2026 and 2025 has been derived from our
unaudited condensed consolidated financial statements appearing in this Report.

The
following discussion contains forward-looking statements, such as those relating to our plans, objectives, expectations, intentions,
and beliefs, which involve significant risks, uncertainties and assumptions. Our actual results could differ materially from those discussed
in these forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those
identified below and those discussed in the section titled “Cautionary Note Regarding Forward-Looking Statements” in this
Report.

In
particular, readers should note that in this Report, we provide our current estimated timelines for advancing and commercially launching
our business lines, including key assumptions and variables. Based on our management’s experience, expertise and communications
with applicable regulators and other stakeholders (such as third-party contractors), we believe we have a sufficient basis to provide
reasonable timing estimates for our efforts, and our expectation is that we will meet such timing for our proposed business lines. However,
readers are cautioned that our business plans are evolving and remain subject to the completion of ongoing technical, regulatory, and
operational preparations, which are inherently uncertain and risky given the nature of our business and may be affected by factors beyond
our control. Accordingly, no assurances can be given that we will be able to progress and commercially launch our several business lines
as currently anticipated, or that such progress or commercial launches will occur in the timeframes we anticipate, if at all. For further
information, please see the “Cautionary Note Regarding Forward-Looking Statements” and the “Risk Factors” section
of this Report and in our Annual Report on Form 10-K for the year ended September 30, 2025, which was filed on December 18, 2025.

All
references to “we,” “us,” “our” and the “Company” refer to NANO Nuclear Energy Inc.,
a Nevada corporation and its consolidated subsidiaries unless the context requires otherwise.

Overview

We
are a nuclear energy and technology company developing smaller, simpler, and safer advanced clean energy solutions, utilizing proprietary
reactor designs, intellectual property and research methods to build the sustainable energy solutions of the future. Led by a world class
scientific and management team, our business plan involves comprehensive engagement across every sector of the nuclear power and energy
industry, traversing the path from sourcing raw materials through to developing cutting edge advanced nuclear microreactors. Our dedication
extends further, encompassing ambitions within the commercial nuclear fuel transportation sector, of the nuclear energy fuel supply chain,
technology development, and nuclear consulting services.

To
date, we have not generated material revenues. For the three and nine months ended June 30, 2026 and the year ended September 30,
2025, our net loss was approximately $10.1 million, $25.8 million and $40.1 million, respectively, and our accumulated deficit as of
June 30, 2026 and September 30, 2025 was approximately $83.3 million and $57.5 million, respectively.

We
are principally focused on the following four business lines as part of our development strategy:

Column 1Column 2Column 3
Nuclear Reactor Business. We are developing the next generation of advanced nuclear microreactors, with our current principal allocation of time and capital resources directed toward the development of the KRONOS MMR™ Energy System. This high technology readiness (“TRL”) level, high-temperature gas-cooled reactor (“HTGR”), Tristructural-Isotropic (“TRISO”) fueled reactor is designed for both small- and large-scale operations, optimizing between size and output to allow for modularity and easier mass manufacturing, and efficient scalable energy generation. On April 2, 2026, we announced the formal submission of the Construction Permit Application (“CPA”) by The Grainger College of Engineering at The University of Illinois at Urbana- Champaign (“UIUC”), our partner for the KRONOS MMR™ Energy System deployment at the UIUC, to the U.S. Nuclear Regulatory Commission (“NRC”), which was formally accepted for review on May 18, 2026. On June 25, 2026, we further announced the continued progress in the NRC’s formal review of the CPA for the deployment of our KRONOS MMR™ Energy System at the UIUC. We also intend, subject to applicable approvals and arrangements, to supply power generated by the KRONOS MMR™ reactor to the UIUC grid. The reactor is expected to be a full-scale system – analogous to the commercial KRONOS MMR™ reactor we intend to sell and deploy after receiving an operating license. The UIUC project also serves as the reactor which the NRC will be evaluating as part of its licensing process for the entire system under the Part 50 licensing rules and regulations. Subject to the NRC review timeline, completion of required safety and environmental reviews, construction activities, and successful commissioning, we expect the KRONOS MMR™ to achieve initial operation or research availability around 2030. The KRONOS MMR™ reactor is currently under development and is subject to applicable licensing processes required for its potential commercialization as a power-producing product. Until the reactor is fully developed and required approvals are obtained, our development activities are focused on technology demonstration, fuel qualification, and design validation. Our current portfolio of reactors also includes the LOKI MMR™ reactor, a portable nuclear reactor designed for versatility in application and deployment, and particularly utilized for space applications, which is also a HTGR utilizing TRISO fuel, and ZEUS™ reactor, a portable modular solid core battery reactor ideal for military applications. Given that we put our corporate emphasis on the KRONOS MMR™ reactor as our lead project, and the fact that all of our reactor designs, except for the ODIN™ reactor, are within the high-temperature gas-cooled reactor family, in March 2026, we signed a definitive asset purchase agreement, as amended in June 2026, with Cambridge Atomworks (2024) Limited, a United Kingdom based advanced reactor developer who is already developing the ODIN™ technology for us on an outsourced consulting basis, for the sale of our ODIN™ microreactor design and all associated intellectual property to Cambridge Atomworks (2024) Limited. The closing is expected to occur on or before November 30, 2026. As of the date of this Report, the sale of the ODIN assets remains pending. Through the collaboration of our world-renowned nuclear scientists and engineers, the U.S. national nuclear laboratories, and government support, we believe our reactors will have the potential to impact the global energy landscape. Our goal is to commercially launch these products in the 2030s, and we are aiming to commercially launch the KRONOS MMR™ Energy System first in the early 2030s as we are currently dedicating a substantial majority of time and resources to such project. There can be no assurance that we will attain our construction, licensing and commercialization goals for our microreactors as currently anticipated.

26

Column 1Column 2Column 3
Fuel Supply Chain Business. Through our subsidiary, HALEU Energy Fuel Inc., we are also seeking to develop a domestic LEU and HALEU fuel supply chain to supply fuel not only for our own reactors, but also to the broader advanced nuclear reactor industry. In December 2024, we announced that LIST, our related party through common ownership and management (see Note 12 to the accompanying unaudited consolidated financial statements), and our company were selected by the DOE to participate as one of six contract awardees in the DOE’s LEU Acquisition Program. Under the contract awarded to LIST, LIST was selected as the prime contractor, with our Company as the key subcontractor bringing our technical and regulatory expertise in advanced nuclear solutions to the collaboration. We are also evaluating ways to participate in other key aspects of the nuclear fuel supply chain through commercial agreements or acquisitions to achieve our goal of vertical integration across key aspects of the nuclear fuel cycle. We recently submitted a private proposal to Dioxitek S.A., an Argentinian state-owned nuclear fuel cycle and uranium dioxide production company and the country’s only feedstock manufacturer for nuclear fuel fabrication (“Dioxitek”), relating to the potential joint development by the parties of a natural uranium hexafluoride (UF6) production facility on Dioxitek’s existing infrastructure in Argentina. This development arises from a previously announced Memorandum of Understanding between our company and Dioxitek, executed in August 2025, which established a non-binding framework to assess the current capacities of natural uranium conversion and supporting infrastructure in Argentina. Our submission of the proposal reflects the outcome of this collaborative work, and the preparation and submission of the proposal represents our next step towards the potential development of UF₆ production capacity. Based on our active engagement regarding potential acquisitions or partnerships, we anticipate launching our fuel supply chain business in late 2026 or early 2027, which is dependent on our success in consummating such transactions. As of the date of this Report, we have not yet entered into any definitive agreement for commercially launching our fuel supply chain business. There can be no assurance that we will proceed with the launch as currently anticipated.

[Excerpt truncated for page length; source filing is linked above.]

Latest 10-K MD&A (excerpt)

Latest 10-K Item 7 source: 0001493152-25-028285. The complete FY 2025 MD&A is published at /company/NNE/mda/fy2025/.

Extracted from Item 7 to the first post-MD&A boundary after HTML sanitization. Confidence: high. Filing date: 2025-12-18. Report date: 2025-09-30.

ITEM
7. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The
following discussion should be read in conjunction with our consolidated financial statements and the related notes contained elsewhere
in this Report and in our other Securities and Exchange Commission filings. The following discussion may contain predictions, estimates,
and other forward-looking statements that involve a number of risks and uncertainties, including those discussed under “Risk Factors”
and elsewhere in this Report. These risks could cause our actual results to differ materially from any future performance suggested below.

Overview

We are a nuclear energy and technology company, developing smaller, simpler, and
safer advanced clean energy solutions, utilizing proprietary reactor designs, intellectual property, and research methods, to contribute
towards a sustainable future. Led by a world class scientific and management team, our business plan involves comprehensive engagement
across all sectors of the nuclear power and energy industry, spanning the value chain from sourcing raw materials to the development of
cutting-edge advanced nuclear microreactors. Our dedication extends further, encompassing strategic initiatives within the commercial
nuclear fuel transportation sector, the nuclear energy fuel supply chain, technology development, and nuclear consulting services.

Currently,
we are in the pre-revenue stage and are principally focused on four business lines as part of our development strategy, including our
micro nuclear reactor business, our nuclear fuel processing business, our nuclear fuel transportation business, and our nuclear consultation
services business.

Our
mission is to become a commercially focused, diversified and vertically integrated nuclear energy company that will capture market share
in the very large and growing nuclear energy sector. To implement our plans, since our founding in 2022, our management has had constant
communications with key U.S. government agencies, including the DOE, the INL and ORNL, which are a part of the DOE’s national nuclear
laboratory system. Our company also maintains important collaborations with leading researchers from the Cambridge Nuclear Energy Centre
and The University of California, Berkeley.

Column 1Column 2
57

Overview
of Operational Plan and Estimated Timelines for Corporate Achievements

We
continue to benefit from a global nuclear energy renaissance driven by several long term, sustainable growth trends and significant regulatory
tailwinds. These include growth in AI data centers, industrial reshoring, and broader electrification, all driving a significant need
for clean and reliable power, energy sustainability and independence, and climate mandates requiring reliable zero-emissions energy.
All of this comes in an era of unprecedented bipartisan legislative and policy support in the U.S. for nuclear energy. Equally important,
there is broad recognition that advanced reactors like the ones we are developing will be critical to future clean energy infrastructure.

Over the next twelve months, we will
continue to progress the development of our advanced reactors and our vertically integrated business plan, with estimated
expenditures to be approximately $65 million. This allocation comprises approximately $43 million dedicated to the research,
development, quality assurance, licensing, and physical test work of our microreactors and other technologies, such as our ALIP
technology and fuel transportation system. A further amount of approximately $12 million will be allocated to the development of our
planned HALEU fuel processing facilities alongside LIST, the related-party uranium enrichment company with whom we collaborate and
in which we have made a strategic investment. The remaining approximately $10 million is earmarked for miscellaneous costs essential
to propelling the progress of our microreactors, encompassing the support of current personnel engaged in executive, finance,
accounting, and other administrative functions. We may also utilize our cash resources raised in 2024 and 2025 for acquisitions of
complementary businesses or assets. As such, and for a variety of other factors, our estimated expenditures may differ substantially
from the above estimates and we find it desirable or necessary to utilize cash resources faster than we currently plan.

In early April 2025, we signed a strategic
collaboration with UIUC to construct the first KRONOS MMR™ research reactor on the university’s campus. In mid-April 2025,
we launched a recruitment initiative focused on the Midwest region to support our plans to construct, demonstrate and gain regulatory
approval for full-scale KRONOS MMR™ in both the United States and Canada. In late April 2025, the NRC issued its final
Safety Evaluation (SE) approving the Fuel Qualification Methodology Topical Report (FQM TR) for the advanced fuel design to be used in
our KRONOS MMR™. In July 2025, we announced that we will provide critical engineering and environmental services for our planned
construction and deployment activities at UIUC for the KRONOS MMR™. We anticipate submitting our construction permit application
to the NRC in early 2026, and receiving the construction permit in 2027. However, there can be no assurance that we will be able to meet
this anticipated timeline, as the submission is subject to the completion of ongoing technical, regulatory, and operational preparations,
which may be affected by factors beyond our control. Notwithstanding the foregoing, this is expected to be the first construction permit
for a microreactor issued in the United States. The permit application will not incur any government fees, as the KRONOS MMR™ reactor,
due to its location at UIUC, qualifies for a fee exemption under applicable regulations due to its use for research purposes.

We have already made material progress
with the KRONOS MMR™, including affirming the collaboration for this project with UIUC; however, we have not yet determined a definitive
timeline for demonstration, licensing and commercial launch of this reactor, but when considering construction timelines, licensing timeframes,
sourcing key materials and fuel, we estimate the early 2030s for commercial readiness.

With respect to the LOKI MMR™ system,
we are still in the process of assessing and developing demonstration, licensing and commercial launch timelines for this reactor. We
also plan on providing nuclear service support and consultation services for the expanding and resurgent nuclear energy industry in 2026,
both domestically and internationally.

With respect to our ZEUS reactor, we are
examining slight modifications of the design to create an even smaller, more mobile reactor system, allowing for an increased number of
applications which do not overlap with our other reactors, KRONOS and LOKI. The solid core concept permits a degree of simplicity, and
fewer working parts, than other reactor types – we are working on exploiting these inherent advantages to provide this product in
the market.

Given our corporate emphasis on the
KRONOS MMR™ reactor and the fact that all of our reactor designs, except for the ODIN™ reactor, are within
the high-temperature gas-cooled reactor family, we are considering strategic alternatives for ODIN. In September 2025, we signed a letter
of intent for the proposed sale of our ODIN™ microreactor design and all associated intellectual property to Cambridge Atom
Works, our commercial collaborator for the ODIN™ project. This transaction is intended to monetize our investment in the
project to date and enable us to allocate more time and resources to the KRONOS MMR™ reactor and our other designs
and technologies.

Readers are cautioned that no assurances
can be given that we can meet successfully the above-mentioned timelines. We are examining strategic acquisitions to expand our business
and consultancy services. We have commenced several material discussions with potential targets for such acquisitions, but as of the date
of this Report, we have not entered into any definitive agreements for such acquisitions.

Moreover, the outlined expenditures and
the anticipated timelines for execution of our plans discussed above and throughout this Management’s Discussion and Analysis of
Financial Condition and Results of Operations are estimations only. These are inherently subject to change due to certain factors, including
adjustments in the microreactor development plan and uncertainties associated with the governmental licensing approval process. Given
that these elements may exceed our initial expectations or lie beyond our control, we cannot guarantee the accuracy of the actual expenditures
and timelines.

As of the date of this Report, we have
not generated any revenues. We have incurred accumulated net losses of $57,500,857 since inception through September 30, 2025.

Column 1Column 2
58

Factors
and Trends Affecting Our Business and Results of Operations

Our
Ability to Develop Our Microreactors

Our results of
operations and our long-term prospects are significantly influenced by factors and trends related to the development,
commercialization, and regulatory advancement of our microreactors. KRONOS™ reactor is our lead reactor program and is being
designed as an advanced, high-temperature microreactor intended for deployment in industrial environments, defense applications, and
other off-grid settings requiring resilient, emissions-free power. The following factors and trends have impacted, and we expect
will continue to impact, our KRONOS development program and our operating results.

Development of
the KRONOS™ reactor is affected by the evolving regulatory framework for advanced non-light-water reactors. The U.S. Nuclear Regulatory
Commission (“NRC”) continues to refine guidance applicable to microreactor licensing, including siting, emergency planning,
fuel qualification, and security requirements. Changes in NRC expectations, the need for additional data or analysis, or delays in regulatory
review may impact our development timelines and costs. In addition, university-based demonstration efforts, including our ongoing collaboration
with the University of Illinois Urbana–Champaign (“UIUC”), will require coordination with federal and state agencies,
which may introduce uncertainties in scheduling and scope.

KRONOS™ reactor
development relies on strategic collaborations with academic institutions and research organizations. Our work with UIUC includes
analyses of siting suitability, infrastructure requirements, and potential demonstration pathways. Such partnerships provide access
to technical expertise and research infrastructure but may be influenced by academic scheduling, funding availability, or
institutional priorities. Delays or changes in partner capacity could affect program timelines.

KRONOS™ technology
incorporates materials and components that require specialized fabrication processes, including high-temperature alloys, advanced
coatings, and precision-engineered reactor structures. Global supply-chain conditions, vendor qualification requirements, and the
availability of domestic manufacturing capacity will affect development costs and timelines. Government incentives for advanced
reactor supply chains may reduce uncertainties, but broader economic factors—including inflationary pressures, material cost
volatility, and logistics constraints—may continue to impact the program.

The LOKI MMR™ reactor originated
as a compact, transportable nuclear microreactor design. The reactor is designed for versatility across terrestrial, marine, and space
applications. It is engineered to deliver on the order of 1 MWth to around 5 MWth of power, making it suitable for remote deployments,
off-grid energy needs, critical infrastructure support, and other distributed energy use-cases

[Excerpt truncated for page length; the complete text is on the linked full-MD&A page.]

Read the full FY 2025 MD&A or browse all MD&A years.

MD&A history

Prior-year 10-K MD&A spans are extracted from SEC filings with the same bounded parser used for the latest filing. Each year's full verbatim text is on its own sub-page.

Macro cross-references for NNE

Indicators mapped to this company's SIC classification (industry 4911 Electric Services) by grepcent's deterministic macro-sector crosswalk. A navigational mapping, not a statistical or causal claim.

Macro-to-micro threads including this sector: Money & trade, Trade & external.

All 71 macro indicators →

For LLMs & downloads

Markdown twin: /company/NNE.md · JSON record: /company/NNE.json · verified financials: JSON / CSV · machine TOC for the whole site: /llms.txt